P1/P1' modified HIV protease inhibitors as tools in two new sensitive surface plasmon resonance biosensor screening assays.

The commonly used HIV-1 protease assays rely on measurements of the effect of inhibitions on the hydrolysis rate of synthetic peptides. Recently an assay based on surface plasmon resonance (SPR) was introduced. We have taken advantage of the fact that the SPR signal is proportional to the mass of the analyte interacting with the immobilised molecule and developed two new improved efficient competition assay methods. Thus, high molecular weight binders were used as amplifiers of the surface plasmon resonance signal. Linkers were attached by a Heck reaction to the para-positions of the P1/P1' benzyloxy groups of a linear C2-symmetric C-terminal duplicated inhibitor to enable (a) biotin labelling or (b) direct immobilisation of the inhibitor to the biosensor surface matrix. The interaction properties of a series of 17 structurally diverse inhibitors was assessed and compared to previously reported data. The most sensitive assay was obtained by immobilising the enzyme and amplifying the signal with an antibody, giving a detection range between 0.1 nM and 10 microM. Immobilisation of the inhibitor resulted in a stable and durable surface but a narrower detection range (1-100 nM). The two competition assays are anticipated to be very suitable for fast screening of potential HIV inhibitors.

[1]  M. Hämäläinen,et al.  Determination of interaction kinetic constants for HIV-1 protease inhibitors using optical biosensor technology. , 2001, Analytical biochemistry.

[2]  J. Louis,et al.  Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV. , 1989, Biochemical and biophysical research communications.

[3]  L. Stolz Chapter 29 - The Use of Surface Plasmon Resonance Based Biosensors in Drug Discovery , 1998 .

[4]  R. Heck Palladium reagents in organic syntheses , 1985 .

[5]  R. Karlsson,et al.  Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. , 1991, BioTechniques.

[6]  I. Beletskaya,et al.  The heck reaction as a sharpening stone of palladium catalysis. , 2000, Chemical reviews.

[7]  L. Vrang,et al.  Design and fast synthesis of C-terminal duplicated potent C(2)-symmetric P1/P1'-modified HIV-1 protease inhibitors. , 1999, Journal of medicinal chemistry.

[8]  B. Persson,et al.  Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins , 1991 .

[9]  C. Leblanc,et al.  Combinatorial chemistry as a tool for drug discovery. , 1999, Progress in medicinal chemistry.

[10]  Gary T. Wang,et al.  Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. , 1990, Science.

[11]  R. Heck Palladium‐Catalyzed Vinylation of Organic Halides , 2005 .

[12]  R. Karlsson,et al.  Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors. , 1994, Analytical biochemistry.

[13]  A. Tomasselli,et al.  Targeting the HIV-protease in AIDS therapy: a current clinical perspective. , 2000, Biochimica et biophysica acta.

[14]  D C Spellmeyer,et al.  Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library. , 1994, Journal of medicinal chemistry.

[15]  M. Hämäläinen,et al.  Screening of compounds interacting with HIV-1 proteinase using optical biosensor technology. , 1998, Analytical Biochemistry.

[16]  T. Meek,et al.  Chromophoric peptide substrates for the spectrophotometric assay of HIV-1 protease. , 1990, Biochemical and biophysical research communications.

[17]  Magnus Malmqvist,et al.  Biospecific interaction analysis using biosensor technology , 1993, Nature.

[18]  Bo Johnsson,et al.  A novel hydrogel matrix on gold surfaces in surface plasmon resonance sensors for fast and efficient covalent immobilization of ligands , 1990 .